| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Australia | 4 | |
| #4 | China | 4 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | Brazil | 2 | |
| #7 | Canada | 2 | |
| #8 | Hong Kong | 2 | |
| #9 | Republic of Korea | 2 | |
| #10 | Mexico | 2 | |
| #11 | Israel | 1 | |
| #12 | Morocco | 1 | |
| #13 | Philippines | 1 | |
| #14 | Singapore | 1 | |
| #15 | Taiwan | 1 | |
| #16 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Organic fine chemistry | |
| #2 | Pharmaceuticals | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Acyclic or carbocyclic compounds | |
| #4 | Organic chemistry methods | |
| #5 | Medical preparations | |
| #6 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Guoqing Paul | 27 |
| #2 | Yan Changren | 13 |
| #3 | Guoqing Paul Chen | 6 |
| #4 | Changren Yan | 5 |
| #5 | Monica Chen | 4 |
| #6 | Chen Monica | 2 |
| #7 | Reale Michael | 2 |
| #8 | Li Yingyin | 1 |
| #9 | Chen Guoqing | 1 |
| #10 | Chen Guoqins Paul | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020181214A1 | Using catequentinib (anlotinib) combining with standard chemotherapy or immunotherapy in sequential order for the cancer treatment | |
| AU2016293841A1 | Fused quinoline compunds as pi3k/mTor inhibitors | |
| US2016326138A1 | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts | |
| CN105722840A | Fused quinoline compunds as PI3K, mTOR inhibitors | |
| CN104936946A | Process for preparing anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline |